Francisca Guijarro

17PUBLICATIONS
78CO-AUTHORS
Gene mappingCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMedical microbiology not elsewhere classifiedMedical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 09, 2026
Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Sara Torres-Esquius, Guillermo Ramil, Maria Gabarrós-Subirà

|Aug 06, 2025
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

Lorena Pérez-Amill, Mercedes Armand-Ugón, Maria Val-Casals

|May 14, 2025
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

Carlos Jimenez-Vicente, Aina Cardus, Sandra Castaño-Diez

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|Jan 08, 2025
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.

Alexandra Martínez-Roca, Carlos Jiménez-Vicente, Beatriz Merchán

|Oct 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.

Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti

Pageof 3

Frequent Collaborators

8 joint publications

Sandra Castaño-Díez

7 joint publications

Jordi Esteve

6 joint publications

Alex Bataller

6 joint publications

Dolors Colomer